Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/71409/1/j.1600-6143.2006.01565.x.pd
Lung transplantation has become an accepted treatment for end-stage pulmonary parenchymal and vascul...
Fungal infections are a significant source of morbidity in the lung transplant population via direct...
Abstract Background Bacterial respiratory infections (BRI) are major complications contributing to i...
Current trends in the epidemiology, outcome and vari-ables influencing mortality in bacteremic lung ...
We aimed to describe the prevalence, risk factors, morbidity and mortality associated with the occur...
Objectives: Our aim was to analyze the prevalence of multidrug-resistant bacterial infections in lun...
Backgrounds: Infectious complication is an important cause of poor outcome of lung transplantation (...
Background : Aiming to improve outcome of lung transplantation (LTx) patients, we reviewed risk fact...
Copyright © 2020. Published by Elsevier Inc. PURPOSE: This study assessed respiratory pathogens isol...
Background: Multidrug-resistant (MDR) bacteria in the lower respiratory tracts of allografts may be ...
Objective: At the time of lung transplant, we routinely perform bronchoalveolar lavage (BAL) of the ...
Lung transplantation has become an accepted treatment for end-stage pulmonary parenchymal and vascul...
Lung transplant recipients are at greater risk of respiratory viral infections as compared to other ...
Bacteriophage therapy (BT) uses bacteriophages to treat pathogenic bacteria and is an emerging strat...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/71603/1/j.1600-6143.2008.02186.x.pd
Lung transplantation has become an accepted treatment for end-stage pulmonary parenchymal and vascul...
Fungal infections are a significant source of morbidity in the lung transplant population via direct...
Abstract Background Bacterial respiratory infections (BRI) are major complications contributing to i...
Current trends in the epidemiology, outcome and vari-ables influencing mortality in bacteremic lung ...
We aimed to describe the prevalence, risk factors, morbidity and mortality associated with the occur...
Objectives: Our aim was to analyze the prevalence of multidrug-resistant bacterial infections in lun...
Backgrounds: Infectious complication is an important cause of poor outcome of lung transplantation (...
Background : Aiming to improve outcome of lung transplantation (LTx) patients, we reviewed risk fact...
Copyright © 2020. Published by Elsevier Inc. PURPOSE: This study assessed respiratory pathogens isol...
Background: Multidrug-resistant (MDR) bacteria in the lower respiratory tracts of allografts may be ...
Objective: At the time of lung transplant, we routinely perform bronchoalveolar lavage (BAL) of the ...
Lung transplantation has become an accepted treatment for end-stage pulmonary parenchymal and vascul...
Lung transplant recipients are at greater risk of respiratory viral infections as compared to other ...
Bacteriophage therapy (BT) uses bacteriophages to treat pathogenic bacteria and is an emerging strat...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/71603/1/j.1600-6143.2008.02186.x.pd
Lung transplantation has become an accepted treatment for end-stage pulmonary parenchymal and vascul...
Fungal infections are a significant source of morbidity in the lung transplant population via direct...
Abstract Background Bacterial respiratory infections (BRI) are major complications contributing to i...
DOI
Add to ORKG